Index | PMF (n = 24) | PV (n = 80) | ET (n = 68) | P | |||
---|---|---|---|---|---|---|---|
Whole group | PMF vs. PV | PMF vs. ET | PV vs. ET | ||||
Age(year) | 65.5(42–78) | 58(21–78) | 57(18–77) | 0.122 | |||
sex | 0.180 | ||||||
male | 17 | 49 | 35 | ||||
female | 7 | 31 | 33 | ||||
abnormal chromosome | 6 | 5 | 2 | < 0.001* | 0.003* | 0.001* | 0.686 |
JAK2 V617Fmutation | 15 | 73 | 47 | < 0.001* | 0.007* | 0.723 | 0.005* |
Splenomegaly | 24 | 58 | 23 | < 0.001* | 0.003* | < 0.001* | < 0.001* |
Thrombosis | 2 | 13 | 12 | 0.550 | 0.511 | 0.342 | 0.821 |
hemorrhage | 1 | 5 | 1 | 0.341 | 0.578 | 0.456 | 0.219 |
Leukaemia | 1 | 0 | 0 | 0.045 | 0.231 | 0.261 | / |
Bone fibrosis | / | 2 | 3 | 0.661 | 0.661 | ||
High LDH | 24 | 56 | 39 | 0.001* | 0.002* | < 0.001* | 0.110 |